Eleven Biotherapeutics reported $0 in Loan Capital for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Amgen AMGN:US $ 36010M 2788M
Bayer BAYN:GR € 36648M 167M
Bristol Myers Squibb BMY:US $ 37450M 2155M
Corcept Therapeutics CORT:US $ 0M 0M
Eleven Biotherapeutics EBIO:US $ 0 0
Eli Lilly And LLY:US $ 15152.9M 193.5M
Intrexon XON:US $ 201.11M 18.36M
Merk MRK:US $ 30586M 104M
Pfizer PFE:US $ 35656M 539M
Rigel Pharmaceuticals RIGL:US $ 29.85M 9.93M
Ziopharm Oncology ZIOP:US $ 10.32M 5.93M